Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Research finds Masimo index to be effective in CHD detection
Study results showed that combined neonatal examination and oxygen saturation screening detected only 78% of the newborns with LHOD, but when perfusion index (PI) was added, 100% of
Study results showed that combined neonatal examination and oxygen saturation screening detected only 78% of the newborns with LHOD, but when perfusion index (PI) was added, 100% of
The primary endpoint of this trial is the extent and duration of local control, that is, the absence of tumor recurrence or progression in the area that has
Under the terms of these new five-year agreements, the University of Miami Tissue Bank and AlloSource will provide Tutogen with various human tissues used in Tutogen dental, spinal
Stem Cell Technologies owns a worldwide exclusive license to a technology developed by researchers at the University of Louisville to identify and isolate rare stem cells from adult
Regenetech’s agreement with Johns Hopkins University will span over two years, and involves significant funding from the company. The goal of the research project is to develop a
In the study, asenapine 5mg twice daily was significantly more effective than placebo in improving both positive and negative symptoms associated with schizophrenia, based on the positive and
Xenazina (tetrabenazine), a dopamine depleting agent, was exclusively licensed by Cambridge to Chiesi in 2003 for commercialisation in Italy. The approval of Xenazina in Italy follows on from
The studies will document the rate at which the Aethlon hemopurifier captures infectious forms of human immunodeficiency virus (HIV), including multi-drug resistant strains of the virus. The studies
The study suggests that circulating serum levels of YKL-40 increased in patients with asthma, compared to those without disease, and correlate with asthma severity. In the study of
As part of the agreement, BrainLAB will supply and install its iPlan Flow software at all clinical sites participating in the pre-pivotal trial. The software will incorporate patient-specific